Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

<p>Supplementary Figure 6: Overall Survival according to PTEN mutation status in the group of IDH-wildtype glioblastomas (n = 362).</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Tobias Kessler (17079209) (author)
Autres auteurs:	Daniel Schrimpf (17079212) (author), Laura Doerner (17079215) (author), Ling Hai (17079218) (author), Leon D. Kaulen (17079221) (author), Jakob Ito (17079224) (author), Martin van den Bent (17079227) (author), Martin Taphoorn (17079230) (author), Alba A. Brandes (17079233) (author), Ahmed Idbaih (17079236) (author), Julien Dômont (17079239) (author), Paul M. Clement (15044256) (author), Mario Campone (15027156) (author), Martin Bendszus (17079242) (author), Andreas von Deimling (15037904) (author), Felix Sahm (15097382) (author), Michael Platten (15018165) (author), Wolfgang Wick (15018168) (author), Antje Wick (17079245) (author)
Publié:	2025
Sujets:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires